OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China
Takaaki Mizuno, Yuki Katsuya, Jun Sato, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Takaaki Mizuno, Yuki Katsuya, Jun Sato, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Showing 15 citing articles:
Recent advances and remaining challenges in lung cancer therapy
Tasha Barr, Shoubao Ma, Zhixin Li, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 5, pp. 533-546
Open Access | Times Cited: 14
Tasha Barr, Shoubao Ma, Zhixin Li, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 5, pp. 533-546
Open Access | Times Cited: 14
N6-methyladenosine RNA modification in PD-1/PD-L1: Novel implications for immunotherapy
Luo Ping, Shiqi Li, Xinghua Long
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188873-188873
Closed Access | Times Cited: 16
Luo Ping, Shiqi Li, Xinghua Long
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188873-188873
Closed Access | Times Cited: 16
Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 7
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 7
Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer
Bei Zuo, Tao Li, Xiaoyun Liu, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 11, pp. 3188-3202
Open Access | Times Cited: 16
Bei Zuo, Tao Li, Xiaoyun Liu, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 11, pp. 3188-3202
Open Access | Times Cited: 16
The regulatory approvals of immune checkpoint inhibitors in China and the United States: A cross‐national comparison study
Yan Jin, Hongtao Li, Pei Zhang, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 11, pp. 2351-2361
Closed Access | Times Cited: 13
Yan Jin, Hongtao Li, Pei Zhang, et al.
International Journal of Cancer (2023) Vol. 152, Iss. 11, pp. 2351-2361
Closed Access | Times Cited: 13
A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
Su He Wang, Zhengyi Cao, Mohammad Farazuddin, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 5
Su He Wang, Zhengyi Cao, Mohammad Farazuddin, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 5
Initial Treatment Modalities in Patients with Newly Diagnosed Primary Lung Cancer in Japan
Qingqing Hu, Kuan‐Chih Huang, Ko Nakajo, et al.
Current Oncology (2025) Vol. 32, Iss. 1, pp. 32-32
Open Access
Qingqing Hu, Kuan‐Chih Huang, Ko Nakajo, et al.
Current Oncology (2025) Vol. 32, Iss. 1, pp. 32-32
Open Access
What is the optimal duration, dose and frequency for anti-PD1 therapy of non-small cell lung cancer?
Chii Yang Kuah, Robert Monfries, Matteo Quartagno, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 5
Chii Yang Kuah, Robert Monfries, Matteo Quartagno, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 5
Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
Dani Ran Castillo, Won Jin Jeon, Daniel Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11547-11547
Open Access | Times Cited: 4
Dani Ran Castillo, Won Jin Jeon, Daniel Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11547-11547
Open Access | Times Cited: 4
Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy
Liya Bai, Hui Liu, Ran You, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2148-2162
Closed Access | Times Cited: 1
Liya Bai, Hui Liu, Ran You, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 5, pp. 2148-2162
Closed Access | Times Cited: 1
Cytochalasin H enhances sensitivity to gefitinib in non-small-cell lung cancer cells through inhibiting EGFR activation and PD-L1 expression
Guihong Zhang, Jiao Liu, Sanzhong Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Guihong Zhang, Jiao Liu, Sanzhong Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in mice
Linyue Pan, Lu Hu, Mengjie Chen, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 4179-4194
Open Access | Times Cited: 2
Linyue Pan, Lu Hu, Mengjie Chen, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 12, pp. 4179-4194
Open Access | Times Cited: 2
Promising preclinical models for lung cancer research—lung cancer organoids: a narrative review
Xinru Chen, Ye Li, Hao Wang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 3, pp. 623-634
Open Access
Xinru Chen, Ye Li, Hao Wang, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 3, pp. 623-634
Open Access
Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies
Konstantin Penkov, Igor Bondarenko, Daria Viktorovna Saenko, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Konstantin Penkov, Igor Bondarenko, Daria Viktorovna Saenko, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Breaking Barriers in Lung Cancer Research: The Intriguing Connection between IL-1β and PD-1/PD-L1 Pathways
Dani Ran Castillo, Won Jin Jeon, Daniel Park, et al.
(2023)
Open Access | Times Cited: 1
Dani Ran Castillo, Won Jin Jeon, Daniel Park, et al.
(2023)
Open Access | Times Cited: 1
